Press/Media items

Closing the door: Breaking new ground related to a potential anticancer drug target

Press/Media: Public Engagement ActivitiesPopular

31/07/2019
In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid glutamine to enter cells and is upregulated in many types of cancer cells, which need more glutamine. It is a potential target for new anti-cancer drugs. Researchers have now elucidated a structure of the human ASCT2 that provides unprecedented insight in the workings of this protein.

References

Related Publications
  1. A one-gate elevator mechanism for the human neutral amino acid transporter ASCT2

    Garaeva, A. A., Guskov, A., Slotboom, D. J. & Paulino, C., 31-Jul-2019, In : Nature Communications. 10, 8 p., 3427.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (1) »

ID: 94825292